The Aorto-Uni-Iliac (AUI) Configuration for EVAR: Clinical Application and Early Outcomes  by Kiguchi, Misaki M. et al.
Table. Characteristics and results in patients recieving AUI vs bifurcated
endografts
AUI (n ¼ 128)
Bifurcated
(n ¼ 1305)
P
value
Demographics
Female 18.8% (24/128) 10.0% (131/1305) <.01
Cardiac disease 64.8% (83/128) 52.8% (689/1304) .01
Chronic obstructive
pulmonary disease
49.6% (62/125) 27.7 (357/1287) <.01
Carotid artery disease 26.5% (30/113) 12.0% (134/1113) <.01
Cerebrovascular disease 21.1% (27/128) 14.5% (189/1304) .05
Peripheral vascular disease 48.4% (61/125) 18.1% (233/1290) <.01
American Society of
Anesthesiologists
class IV
22.7% (29/128) 8.5% (111/1304) <.01
Society for Vascular
Surgery 3
41.8% (51/122) 34.1% (431/1265) .09
Operative results
Duration of implant time
(min)
110.9 6 54.9 99.2 6 44.3 .02
General anesthesia 80.5% (103/128) 63.5% (828/1304) <.01
EBL (cc) 247.8 6 259.6 204.2 6 210.0 <.01
30-day outcomes
Mean hospital stay, days 6.2 6 6.7 5.9 6 6.3 .61
Mean intensive care unit
stay, hours
19.6 6 80.0 9.0 6 34.8 .01
Mortality 2.3% (3/128) 1.1% (14/1305) .21
Procedural blood loss
>1000 cc
3.1% (4/128) 1.3% (17/1305) .11
Myocardial infarction 3.9% (5/128) 1.0% (13/1305) <.01
Endoleaks 12.8% (16/125) 11.6% (151/1297) .70
1-year outcomes
All-cause mortality 10.7% (13/122) 7.0% (90/1280) .14
Stent graft occlusion 3/1% (4/118) 3/1% (41/1305) .88
Endoleaks 6.1% (7/114) 8.6% (111/1287) .36
Abdominal aortic aneu-
rysm diameter decrease
44.6% (41/92) 41.7% (405/972) .59
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Objectives: We describe a case of a 59-year-old male with a history of
left subclavian to descending thoracic aortic bypass for coarctation 38 years
ago, who presented with 2 months of hemoptysis. A computed tomography
(CT) angiogram revealed disruption of the distal anastomosis with aortopul-
monary ﬁstula, and descending thoracic aortic aneurysm. The patient was
successfully treated endovascularly.
Methods: The patient had a history of aortic coarctation just distal
to the left subclavian artery that was repaired 38 years ago with a left
subclavian artery to aorta bypass using a 14-mm Dacron graft. A CT
scan showed a patent 6-mm coarctation, disruption of the distal anasto-
mosis with hemorrhage into the adjacent lung parenchyma, and a postste-
notic dilatation of the descending thoracic aorta. Open repair was
considered but dismissed in favor of endovascular approach secondary to
the difﬁcult location of the anastomosis and probable adhesions from the
previous surgery. Challenges for an endovascular repair included the feasi-
bility of dilating the coarctation, need to cover left subclavian artery, and
need to occlude the previous bypass graft. Utilizing a bilateral femoral
approach, the coarctation was ﬁrst dilated with a 12-mm angioplasty
balloon. The previous subclavian artery to aorta bypass was then embol-
ized using an Amplatzer plug. Finally, two Gore TAG and one Cook
TX2 thoracic endografts were deployed, covering the left subclavian artery,
crossing the coarctation, and covering the descending thoracic aortic aneu-
rysm (Fig).
Results: The completion angiogram showed no evidence of endoleak
and complete occlusion of the previous bypass. The hemoptysis resolved
immediately, and the patient had no signs or symptoms of left arm ischemia.
The patient will be followed with physical exam, pressure gradients between
upper and lower extremities, and CT scans.
Conclusions: Endovascular repair of a failing left subclavian to aorta
bypass is a favorable alternative to open repair.
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Objectives: Deﬁne the anatomic indications and early results of AUI
for endovascular aneurysm repair (EVAR).
Methods: 128 patients receiving an Endurant (Medtronic, Santa
Rosa, Calif) AUI in the US IDE trial (44) or the Global Postmarket
ENGAGE registry (84) were reviewed. Preop computed tomography scans
of IDE patients and case report forms of registry patients were used to
determine anatomic indications. Baseline characteristics and early results
were compared with 1305 patients receiving a bifurcated device (BIF) in
sister studies
Results: The indication for AUI was unclear from case report forms in
18 registry cases. The remaining 110 patients had a unilateral iliac occlusion
in 29 (26.4%), a narrow aortic segment <16 mm in 40 (36.4%), severe iliac
occlusive disease in 25 (22.7%), severe iliac tortuosity in 28 (25.5%), or iliac
aneurysms in 19 (17.3%). Thirty-seven patients had multiple indications.
Baseline characteristics and early outcomes are in the Table. The AUI
cohort included more women and had more severe comorbidities than the
BIF group. Successful deployment was achieved in all AUI cases. Thirty-day
mortality was 2.3%. More AUI patients were done under general anesthesia
and procedures were slightly longer. Except for longer intensive care unit
stays and higher myocardial infarction rates, AUI outcomes were similar to
the BIF cohort. There were no migrations, ruptures, fractures, or open
conversions up to 1 year.
Conclusions: The AUI conﬁguration extends EVAR feasibility to
several hostile anatomies. Despite increased comorbidities, early outcomes
using AUI devices are similar to patients treated with a BIF conﬁguration
